Literature DB >> 11467936

Independent Lec1A CHO glycosylation mutants arise from point mutations in N-acetylglucosaminyltransferase I that reduce affinity for both substrates. Molecular consequences based on the crystal structure of GlcNAc-TI.

W Chen1, U M Unligil, J M Rini, P Stanley.   

Abstract

A key enzyme in regulating the maturation of N-linked glycans is UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I (GlcNAc-TI, EC 2.4.1.101). Lec1 CHO cells lack GlcNAc-TI activity and synthesize only the oligomannosyl class of N-glycans. By contrast, Lec1A CHO mutants have weak GlcNAc-TI activity due to the reduced affinity of GlcNAc-TI for both the UDP-GlcNAc and Man(5)GlcNAc(2)Asn substrates. Lec1A CHO mutants synthesize hybrid and complex N-glycans, albeit in reduced amounts compared to parental CHO cells. In this paper, we identify two point mutations that gave rise to the Lec1A phenotype in three independent Lec1A CHO mutants. The G634A mutation in Lec1A.2C converts an aspartic acid to an asparagine at amino acid 212, disrupting a conserved DXD motif (E(211)DD(213) in all GlcNAc-TIs) that makes critical interactions with bound UDP-GlcNAc and Mn(2+) ion in rabbit GlcNAc-TI. The C907T mutation in Lec1A.3E and Lec1A.5J converts an arginine conserved in all GlcNAc-TIs to a tryptophan at amino acid 303, altering interactions that are important in stabilizing a critical structural element in rabbit GlcNAc-TI. Correction of each mutation by site-directed mutagenesis restored their GlcNAc-TI activity and lectin binding properties to parental levels. The effect of the two amino acid changes on GlcNAc-TI catalysis is discussed in relation to the crystal structure of rabbit GlcNAc-TI complexed with manganese and UDP-GlcNAc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467936     DOI: 10.1021/bi015538b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Rapid assays for lectin toxicity and binding changes that reflect altered glycosylation in mammalian cells.

Authors:  Pamela Stanley; Subha Sundaram
Journal:  Curr Protoc Chem Biol       Date:  2014-06-03

2.  Substrate specificities and intracellular distributions of three N-glycan processing enzymes functioning at a key branch point in the insect N-glycosylation pathway.

Authors:  Christoph Geisler; Donald L Jarvis
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

3.  Molecular basis of N-acetylglucosaminyltransferase I deficiency in Arabidopsis thaliana plants lacking complex N-glycans.

Authors:  Richard Strasser; Johannes Stadlmann; Barbara Svoboda; Friedrich Altmann; Josef Glössl; Lukas Mach
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

4.  Antitumor Efficacy of Anti-GD2 IgG1 Is Enhanced by Fc Glyco-Engineering.

Authors:  Hong Xu; Hongfen Guo; Irene Y Cheung; Nai-Kong V Cheung
Journal:  Cancer Immunol Res       Date:  2016-05-16       Impact factor: 11.151

5.  Mutational and functional analysis of Large in a novel CHO glycosylation mutant.

Authors:  Jennifer T Aguilan; Subha Sundaram; Edward Nieves; Pamela Stanley
Journal:  Glycobiology       Date:  2009-05-21       Impact factor: 4.313

6.  Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.

Authors:  Josef Voglmeir; Sara Kaloo; Nicolas Laurent; Marco M Meloni; Lisa Bohlmann; Iain B H Wilson; Sabine L Flitsch
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

7.  Unaltered complex N-glycan profiles in Nicotiana benthamiana despite drastic reduction of beta1,2- N -acetylglucosaminyltransferase I activity.

Authors:  Richard Strasser; Friedrich Altmann; Josef Glössl; Herta Steinkellner
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.